ORKA logo

ORKA
Oruka Therapeutics Inc.

270
Mkt Cap
$2.95B
Volume
1.02M
52W High
$64.61
52W Low
$7.62
PE Ratio
-25.70
ORKA Fundamentals
Price
$59.58
Prev Close
$63.60
Open
$63.47
50D MA
$39.21
Beta
1.15
Avg. Volume
724,004.82
EPS (Annual)
-$2.31
P/B
6.19
Rev/Employee
$0.00
$1,050.38
Loading...
Loading...
News
all
press releases
Oruka Therapeutics (NASDAQ:ORKA) Shares Down 6.4% - Should You Sell?
Oruka Therapeutics (NASDAQ:ORKA) Trading Down 6.4% - Should You Sell...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Oruka Therapeutics (NASDAQ:ORKA) Price Target Raised to $78.00 at Barclays
Barclays increased their target price on shares of Oruka Therapeutics from $50.00 to $78.00 and gave the stock an "overweight" rating in a research report on Tuesday...
MarketBeat·4d ago
News Placeholder
Oruka Therapeutics (NASDAQ:ORKA) Trading 5% Higher Following Analyst Upgrade
Oruka Therapeutics (NASDAQ:ORKA) Trading Up 5% After Analyst Upgrade...
MarketBeat·4d ago
News Placeholder
Oruka Therapeutics (NASDAQ:ORKA) Price Target Raised to $75.00 at UBS Group
UBS Group increased their price target on shares of Oruka Therapeutics from $50.00 to $75.00 and gave the company a "buy" rating in a research report on Monday...
MarketBeat·5d ago
News Placeholder
Oruka Therapeutics (NASDAQ:ORKA) Hits New 52-Week High - Here's Why
Oruka Therapeutics (NASDAQ:ORKA) Hits New 52-Week High - Here's Why...
MarketBeat·5d ago
News Placeholder
Secure Asset Management LLC Takes Position in Oruka Therapeutics, Inc. $ORKA
Secure Asset Management LLC purchased a new position in Oruka Therapeutics, Inc. (NASDAQ:ORKA - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and...
MarketBeat·6d ago
News Placeholder
Oruka Therapeutics (NASDAQ:ORKA) Sets New 12-Month High - Should You Buy?
Oruka Therapeutics (NASDAQ:ORKA) Sets New 12-Month High - Time to Buy...
MarketBeat·11d ago
News Placeholder
Oruka Therapeutics, Inc. (NASDAQ:ORKA) Short Interest Down 18.4% in March
Oruka Therapeutics, Inc. (NASDAQ:ORKA - Get Free Report) saw a significant decline in short interest in the month of March. As of March 13th, there was short interest totaling 3,644,487 shares, a decline of 18.4% from the February 26th total of 4,466,793 shares. Currently, 9.8% of the company's...
MarketBeat·12d ago
News Placeholder
458,946 Shares in Oruka Therapeutics, Inc. $ORKA Acquired by Synergy Asset Management LLC
Synergy Asset Management LLC acquired a new stake in Oruka Therapeutics, Inc. (NASDAQ:ORKA - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 458,946 shares of the company's stock, valued at...
MarketBeat·16d ago
News Placeholder
Oruka Therapeutics (NASDAQ:ORKA) Shares Up 5.6% - Here's Why
Oruka Therapeutics (NASDAQ:ORKA) Trading 5.6% Higher - Here's Why...
MarketBeat·16d ago
<
1
2
...
>

Latest ORKA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.